I'd imagine that any hedge fund looking at Pilbara would need to keep their eye on the spodumene price, because any increases closer to the $600 to $650 price would make them nervous.
Also, whilst I havent done my research into offtakes that @SF@HC has shared with me, I am wondering if one concentrator could be focussed on supplying POSCO, or potentially allow for the company to shut down one whilst they expand the other.
Making hay whilst the sun is shining comes to mind, so I'd also be interested in hearing from @MasterStrategist on this because he knows the company far better than I do.. all I have ever done is seen potential and liked a story... And when it came to Pilbara they kept proving me wrong and became better every time I looked at them.
Ann: S&P DJI Announces March 2021 Quarterly Rebalance, page-17
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.85 |
Change
-0.150(5.00%) |
Mkt cap ! $8.582B | |||
| Open | High | Low | Value | Volume |
| $2.95 | $2.98 | $2.83 | $92.31M | 32.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46000 | $2.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.86 | 89829 | 11 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PLS (ASX) Chart |